Ipca Laboratories Ltd.

NSE: IPCALAB | BSE: 524494 | ISIN: INE571A01038 | Industry: Pharmaceuticals
| Mid-range Performer
1424.8000 19.10 (1.36%)
NSE Dec 19, 2025 15:31 PM
Volume: 169.8K
 

1424.80
1.36%
Prabhudas Lilladhar
Q4FY22/Q1FY23. Domestic business (45% of total sales) continues to remain on strong footing and should continue to outperform IPM. Strong API capabilities and diversified model benefit IPCA in the current environment. We recommend Buy' rating on the stock with target price of Rs 2,450 based...
Ipca Laboratories Ltd. is trading above all available SMAs
More from Ipca Laboratories Ltd.
Recommended